BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36795303)

  • 1. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
    El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
    Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
    Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
    BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
    El Hajj MS; Jaam MJ; Awaisu A
    Res Social Adm Pharm; 2018 Jun; 14(6):507-520. PubMed ID: 28641999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.
    Nguyen AT; Wisniewski J; Leang DW; Keller MS; Rosen S; Shane R; Pevnick JM
    J Manag Care Spec Pharm; 2023 Mar; 29(3):266-275. PubMed ID: 36840959
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol.
    Bagyawantha NMY; Coombes ID; Gawarammana I; Fahim M
    BMJ Open; 2023 Feb; 13(2):e059413. PubMed ID: 36759028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial.
    Bell SP; Schnipper JL; Goggins K; Bian A; Shintani A; Roumie CL; Dalal AK; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Labonville SA; Johnson D; Neal EB; Kripalani S;
    J Gen Intern Med; 2016 May; 31(5):470-7. PubMed ID: 26883526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Pharmacist Medication Education and Post-discharge Follow-up in Reducing Readmissions in Patients With ST-Segment Elevation Myocardial Infarction (STEMI).
    Budiman T; Snodgrass K; Komatsu Chang A
    Ann Pharmacother; 2016 Feb; 50(2):118-24. PubMed ID: 26681443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
    Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
    Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Smartphone-Based Model of Care to Support Patients With Cardiac Disease Transitioning From Hospital to the Community (TeleClinical Care): Pilot Randomized Controlled Trial.
    Indraratna P; Biswas U; McVeigh J; Mamo A; Magdy J; Vickers D; Watkins E; Ziegl A; Liu H; Cholerton N; Li J; Holgate K; Fildes J; Gallagher R; Ferry C; Jan S; Briggs N; Schreier G; Redmond SJ; Loh E; Yu J; Lovell NH; Ooi SY
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e32554. PubMed ID: 35225819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
    Arnold ME; Buys L; Fullas F
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
    Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-centered adherence intervention after acute coronary syndrome hospitalization.
    Lambert-Kerzner A; Del Giacco EJ; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Davis R; Mun H; Weaver J; Barnett C; Radcliff T; Hubbard A; Bosket KD; Carey E; Virchow A; Mihalko-Corbitt R; Kaufman A; Marchant-Miros K; Ho PM;
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):571-6. PubMed ID: 22811499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis.
    Nuckols TK; Berdahl CT; Henreid AJ; Schnipper JL; Rauf A; Ko EM; Nguyen AT; Co Z; Fanikos J; Kim JH; Leang DW; Matta L; Mulligan K; Ray A; Shane R; Wassef K; Pevnick JM
    Inquiry; 2023; 60():469580231218625. PubMed ID: 38146178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
    Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
    Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilization.
    Pevnick JM; Keller MS; Kennelty KA; Nuckols TK; Ko EM; Amer K; Anderson L; Armbruster C; Conti N; Fanikos J; Guan J; Knight E; Leang DW; Llamas-Sandoval R; Matta L; Moriarty D; Murry LT; Muske AM; Nguyen AT; Phung E; Rosen O; Rosen SL; Salandanan A; Shane R; Schnipper JL
    Contemp Clin Trials; 2021 Jul; 106():106419. PubMed ID: 33932574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pharmacist discharge medication therapy counseling and disease state education: Pharmacist Assisting at Routine Medical Discharge (project PhARMD).
    Sarangarm P; London MS; Snowden SS; Dilworth TJ; Koselke LR; Sanchez CO; D'Angio R; Ray G
    Am J Med Qual; 2013; 28(4):292-300. PubMed ID: 23033542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist Intervention to Improve Medication Adherence in Patients with Acute Coronary Syndrome: The PRIMA-ACS Study.
    Neville HL; Mann K; Killen J; Callaghan M
    Can J Hosp Pharm; 2021; 74(4):350-360. PubMed ID: 34602623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    BMJ Open; 2016 Feb; 6(2):e010003. PubMed ID: 26908524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.